PDCD1LG2 and esophageal squamous cell carcinoma: Macrophages can also be recruited into the TME to promote immunocyte infiltration via the PD-1/PD-L2 pathway, which may open a new avenue for anticancer immunotherapy in the management of ESCC [58].